Schiller May Be Forced to Pay Back Valeant Up to $26.1 MillionBy and
Clawback policy allows company to recoup pay after restatement
Penalty applies even if executive no longer works for company
Howard Schiller, the embattled Valeant Pharmaceuticals International Inc. director, may be forced to pay back some of the $26.1 million in incentive compensation he received as chief financial officer in 2014.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.